Last reviewed · How we verify
Clenil® Modulite® via AeroChamber Plus™
Clenil Modulite is a corticosteroid that reduces inflammation in the airways.
Clenil Modulite is a corticosteroid that reduces inflammation in the airways. Used for Maintenance and relief of asthma symptoms, Maintenance treatment of chronic obstructive pulmonary disease (COPD).
At a glance
| Generic name | Clenil® Modulite® via AeroChamber Plus™ |
|---|---|
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 2 |
Mechanism of action
Clenil Modulite contains beclometasone dipropionate, a synthetic corticosteroid that works by inhibiting the release of pro-inflammatory mediators from mast cells and other inflammatory cells. This leads to a reduction in airway inflammation and symptoms associated with asthma and other respiratory conditions.
Approved indications
- Maintenance and relief of asthma symptoms
- Maintenance treatment of chronic obstructive pulmonary disease (COPD)
Common side effects
- Oral thrush
- Hoarseness
- Cough
- Headache
- Nausea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: